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New YorkABSTRACT Amyloid diseases, including Alzheimer’s disease, are characterized by aggregation of normally functioning
proteins or peptides into ordered, b-sheet rich fibrils. Most of the theories on amyloid toxicity focus on the nuclei or oligomers
in the fibril formation process. The nuclei and oligomers are transient species, making their full characterization difficult. We
have isolated toxic protein species that act like an oligomer and may provide the first evidence of a stable reactive species
created by disaggregation of amyloid fibrils. This reactive species was isolated by dissolving amyloid fibrils at high pH and it
has a mass >100 kDa and a diameter of 485 15 nm. It seeds the formation of fibrils in a dose dependent manner, but using
circular dichroism and deep ultraviolet resonance Raman spectroscopy, the reactive species was found to not have a b-sheet
rich structure. We hypothesize that the reactive species does not decompose at high pH and maintains its structure in solution.
The remaining disaggregated insulin, excluding the toxic reactive species that elongated the fibrils, returned to native structured
insulin. This is the first time, to our knowledge, that a stable reactive species of an amyloid reaction has been separated and
characterized by disaggregation of amyloid fibrils.INTRODUCTIONAmyloid diseases are characterized by the transformation of
proteins and peptides into ordered b-sheet containing fibrils.
The formation of the fibrils is suspected to proceed through
a nucleation-elongation pathway that is characterized by
a lag phase, where nuclei form and proceed to oligomer
formation, culminating in fibril elongation and growth (1).
Researchers are continuing to search for oligomers and
the nuclei that initiate fibril formation because these entities
may be the cause of amyloid toxicity and disease. Small
Ab oligomers have been shown to impair synaptic plasticity
(2), create holes in cells to cause calcium leakage (3),
and disrupt cellular communication (4). Yet to the contrary,
amyloid fibrils have been shown to pierce cellular mem-
branes causing cell death (5), demonstrating conflicting
information on the oligomer toxicity debate. This debate
will not be satisfied until an amyloid nucleus and oligomers
can be stably formed, isolated, and studied to better under-
stand their structure, function, reactivity, and toxicity.
The structure and function of amyloid oligomers has
eluded us, due to their transient and heterogeneous nature,
but we do have evidence of oligomers. Multiple amyloid
structures that are believed to be oligomers have been
imaged with atomic force microscopy (AFM) and they
appear to have a common round shape with a hollow center
(6). Two different groups have identified the nucleus of
insulin amyloid formation to contain six monomers (7,8),Submitted January 4, 2011, and accepted for publication April 18, 2011.
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Recent evidence shows that hexamer nuclei are common
in nature, but the preferred arrangement of the hexamers
is not circular or a compact equilibrium structure, but a
more irregular structure (9). Electrospray mobility analysis
demonstrated that insulin jumps from a trimer to fibrils
without a detectable hexamer intermediate (10). Recent
in silico predictions confirm this possibility using phase-
diagram analysis (11). The manipulation of solution pH,
ionic strength, and temperature has been shown to create
metastable oligomers of Ab (12,13), but according to Dob-
son and others, it is unclear if metastable oligomers formed
in this manner lead to fibril formation (14).
Without direct evidence of nuclei and oligomers, indirect
methods have given some insight into the structure of
oligomeric species from different peptides and proteins.
Glabe and co-workers have found antibodies that bind
preferentially to Ab oligomers over fibrils or monomers
(15). Toxic oligomers of HypF-N amyloid peptide have
more solvent-accessible hydrophobic domains than do
nontoxic oligomers (16), as has also been shown for Ab
(17) and superoxide dismutase protein (SOD1) (18), found
in amyotrophic lateral sclerosis.
Amyloid fibrils are known to be mechanically strong and
stable. They are known to give structural integrity to biofilms
(19) and have the strength of steel and the stiffness of silk
(20). Fibril can be cleaved and fibril breakage has been sus-
pected as a method of fibril renewal and propagation (21)
and recently, sonication has been used to create uniform
fibrils for study (22). Yet only a few studies have reported
dissolving amyloid fibrils, and with only harsh conditions
like guanidine HCl (23), DMSO (24), and ionic liquidsdoi: 10.1016/j.bpj.2011.04.046
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demonstrated to be pH dependent, with a disaggregation of
fibrils occurring above a pH of 8 (26). We confirm here that
high pH can dissolve insulin amyloid fibrils. Native protein
is released from the fibril, but a small species remains in
a conformation that seeds insulin fibril formation, is toxic
to cells, and has not been fully characterized.
In this study, we used the amyloid protein insulin. It is
a commonly used in vitro amyloid system that in harsh
conditions (65C and pH 1.6) creates long, linear amyloid
fibrils (1,27). Insulin is also a known component of amyloid
plaques in injection-localized insulin amyloidosis (28).
Insulin fibrils have been studied to understand their structure
and the critical region of the protein involved in the cross
b-sheet core of the fibrils (29). Knowing the core amino
acids aides in the understanding of the nucleus before fibril
formation, but it does not give firm evidence of the nucleus
or oligomers. We have formed and recovered a reactive and
toxic species from insulin fibrils by disaggregating the
fibrils using high pH and removing a large amount of insulin
that refolded into normally folded insulin. This reactive
species could be a building block of the fibril formation, it
could be created during dissolution, or it could be carried
by the fibril during the fibril formation/dissolution process.
The reactive species has no-detectable b-sheet content and
is not affected by the high pH environment. The remaining
insulin monomers/dimers, that exhibit near-native state
behavior, can be separated from the reactive species. We
speculate that the reactive species exists during the forma-
tion of insulin fibrils and has a distinct structure and stability
compared with the native insulin that elongates the fibril.MATERIALS AND METHODS
Materials
The insulin was a generous gift from Novo Nordisk (Gentofte, Denmark)
and the membranes used for diafiltration were a generous gift from Milli-
pore (Billerica, MA). All chemicals were purchased from Sigma-Aldrich
(St. Louis, MO) unless otherwise mentioned and all solutions were filtered
with a 0.22 mm filter before use.Aggregation kinetics
Before insulin aggregation, the insulin was pretreated by pH cycling (30).
This reduced the amount of preformed aggregates in the insulin solution
and improved reproducibility. The insulin was then diluted to 2 mg/ml in
insulin buffer (100 mM NaCl, 25 mM HCl, pH 1.6) and the pH adjusted
with 10 M HCl and heated to 65C. Analysis of fibril formation was per-
formed on a Hitachi U-2000 UV-Vis Spectrophotometer (Hitachi High
Technologies America, San Jose, CA) by measurement of the absorbance
at 600 nm. The data were empirically fit to a sigmoidal curve to determine
the lag time and apparent rate constant (1,31).Fibril disaggregation
Fibrils were washed with insulin buffer and concentrated to 20 mg/ml.
Sodium hydroxide (1 M) was added until the pH reached 11.0 (50.2).The solution remained at 22C overnight until the solution was clear.
The disaggregated fibrils were centrifuged at 12,500 rpm in an accuSpin
Micro centrifuge (Fisher Scientific, Waltham, MA) for 15 min to remove
any remaining fibrils.Diafiltration
Toxic insulin reactive species were separated by diafiltration using an
Amicon stirred filtration cell equipped with a solvent reservoir and regen-
erated cellulose membranes with a 100 kDa MWCO from Millipore.
Briefly, solutions of disaggregated fibrils were taken to a pH of 3 with
10 M HCl. We preferred to perform the diafiltration using insulin buffer,
but a pH of 1.6 dissolved the regenerated cellulose membranes, therefore
a pH of 3 was chosen. Diafiltration buffer (100 mM NaCl, pH 3) was added
to the solvent reservoir and the filtration proceeded at a transmembrane
pressure of 10–15 psi for a total of 10 diavolumes. The concentration of
the remaining solutions was measured by the absorbance at 280 nm and
all insulin samples were assumed to have the same extinction coefficient
of 4,785 M1 cm1 (32).Circular dichroism
Circular dichroism (CD) spectra were obtained from a Jasco (Tokyo, Japan)
815 spectrometer at room temperature using four accumulations of spectra
and then smoothing by averaging five consecutive data points. All samples
contained 100 mM NaCl at the specified pH. The CD spectra were decon-
voluted with DichroWeb (33) using the CDSSTR algorithm (34) and the
average of reference data sets 7 and SP175 (35). The melt curves were
obtained every 0.5C from 25 to 90C with a ramp rate of 1C/min. The
retentate melt curve was obtained at 4C/min due to aggregation occurring
at a ramp rate of 1C/min. The melt temperature for the sigmoidal pH 11
samples was calculated as the midpoint of the transition from the lower
temperature baseline to the upper temperature asymptote.Deep ultraviolet resonance Raman
The details of Deep ultraviolet resonance Raman (DUVRR) spectroscopic
measurements have been reported elsewhere (36). Briefly, a 197-nm laser
beam was focused into a spinning Suprasil NMR tube containing 100 mL
of sample solution. Scattered radiation was collected in backscattering
geometry, dispersed using a home-built double monochromator, and de-
tected with a liquid nitrogen-cooled CCD camera (Roper Scientific, Tucson,
AZ). The spectrum was recorded for 10 min. GRAMS/AI (7.01) software
(Thermo Fisher Scientific, Pittsburgh, PA) was used for Raman spectro-
scopic data processing. The contribution of Suprasil, solvent, and buffer
was quantitatively subtracted.Toxicity
Rat neuroendocrine cells (PC-12 adherent, ATCC) were cultured in high-
glucose Dulbecco’s modified Eagle’s medium (Invitrogen, Carlsbad, CA)
supplemented with 5% fetal bovine serum, 10% horse serum, and 1%
penicillin-streptomycin (12). The cells were scrapped from the flask and
re-suspended at a concentration of 1.1  105 cells/ml and 90 ml of cell
suspension was added to each well of a 96-well plate (CellBIND, Corning,
Corning, NY) to adhere for 24 h. Afterward, 10 ml of sample for toxicity
was added and allowed to incubate at 37C, 5% CO2, and 100% humidity
for 48 h. A solution of 5 mg/ml of thiazolyl blue tetrazolium bromide
(MTT) was added at a volume of 10 ml/well and returned to the incubator
for 4–6 h. The solubilization buffer (10% SDS, 0.01M HCl in water) was
added at 100 ml/well and incubated for 4–16 h (37). The absorbance at
562 nm was read on a Tecan (Raleigh, N.C.) Safire2 plate reader and
normalized to the pH 1.6 buffer controls. MTT reduction was defined asBiophysical Journal 100(11) 2792–2800
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multiplied by 100% for a percent of the control.Small angle neutron scattering
Small angle neutron scattering (SANS) was performed on the CG-3 beam
line at Oakridge National Laboratory (Oak Ridge, TN) at room temperature
in deuterated solvents. Detector to sample distances were 1.7 and 6 m. All
spectra were analyzed using the Guinier analysis (7,38), as detailed in the
Methods in the Supporting Material.RESULTS
Properties of disaggregated fibrils
Once insulin fibrils are dissolved using high pH, we hypoth-
esized that the insulin that dissolved from fibrils would be
structurally different from insulin that was not subjected
to the b-sheet rich fibril state. To test this hypothesis, we
examined the structural configurations of different insulin
states. We used native insulin as a control and cycled it
through pH 11 (Fig. 1 A) to determine if the extreme pH
would change the insulin structure and ability to form
amyloid fibrils. In the same manner, insulin fibrils wereFIGURE 1 Disaggregation of insulin fibrils. (A) Native insulin was
cycled to pH 11 (IN) for 1–2 min and returned to pH 1.6 (IN
0) to serve as
a control for the fibril disaggregation. (B) For fibril disaggregation, insulin
fibrils were formed after ~4 h at pH 1.6 and 65C and a concentration of
2 mg/ml insulin. The fibrils were washed and the pH increased to 11(for
16 h). The fibrils were fully disaggregated and any remaining fibrils were
removed by centrifugation (IF), they were returned to pH 1.6 (IF
0) and stored
for several days at this condition. (C) Fibrils that were disaggregated were
separated at pH 3 with diafiltration using a 100 kDa synthetic membrane
to removed native insulin (permeate) and concentrate the oligomers
(retentate).
Biophysical Journal 100(11) 2792–2800formed by a standard method of low pH and increased
temperature for 4 h (1,31), and then followed the same
procedure of pH cycling (Fig. 1 B). A fibrils solution had
a >90% loss in turbidity (as measured by the absorbance
at 600 nm) within 10 min of the pH increase and the pres-
ence of 100 mM NaCl increased this time to 30 min
(Fig. 2 A). It is likely that the combined hydrophobic and
electrostatic interactions hold the fibril structure together
(29,39). The shielding of electrostatic repulsion by salt in
the aggregation buffer has been shown experimentally
(13) and calculated (11) to promote formation of fibrils
for other amyloid proteins. This is likely due to the reduc-
tion of the electrostatic free energy of the amyloid species
and delays fibril disaggregation in salt solutions.
By subjecting native insulin to a pH of 11, there was an
18% (57%) reduction in a-helix content and a 12%
(57%) reduction in b-sheet structure between the native
insulin and the insulin that had cycled through pH 11 and
returned to pH 1.6, which was determined by deconvoluting
the CD curve (Fig. 2 B) using DichroWeb (33). ThisFIGURE 2 Disaggregated insulin fibrils (IF and IF
0) cannot be distin-
guished from native insulin that had been pH-cycled (IN and IN
0). (A) The
disaggregation of insulin fibrils takes ~10 min and is slower (30 min) in
the presence of 100 mM NaCl (red squares) compared with no salt present
(blue diamonds). The secondary structure of insulin that had been in fibrils
(IF
0) was compared with native insulin that had not previously been in fibrils
(IN
0) using B and C CD and D DUVRR. The inset in B shows an enlarged
view of the range that is critical for a-helix content, 208 and 223 nm (41).
By subjecting insulin to pH 11, there was some loss of native insulin struc-
ture, but this appears to be only due to the high pH since insulin that had (IF)
and had not (IN) previously been in a fibril contained the same minor loss of
structure. Key: (B and C) Native insulin pH 1.6 (blue solid line), IN (red
solid squares), IF (red open squares), IN
0 (green solid triangles), and IF0
(green open triangles). (D) Native insulin pH 1.6 (blue solid line), IN
0
(green long dashes), and IF
0 (green dots). Please refer to Fig. 1 for details.
FIGURE 3 Amyloid characteristics of disaggregated insulin. (A) Thiofla-
vin-T (ThT) fluorescence of insulin samples shows that disaggregated
insulin (IF and IF
0) has a ThT signal, whereas native insulin (IN and IN0)
does not. (B) Seeding of IF
0 into a new kinetic run reduces the lag time in
a dose-dependent fashion (blue diamonds). For reference, the control
without seeding is shown as a red square. (C) AFM of IF shows large aggre-
gates 485 15 nm in diameter at pH 11. (D) Fibrils and disaggregated fibrils
(IF
0) demonstrate cellular toxicity by an MTT reduction using PC-12 cells,
whereas insulin that has not been in fibrils (Native insulin) does not reduce
MTT. All MTT samples were added at pH 1.6, but the cell media buffered
the samples to pH 7.4.
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an increase in disordered structure. Similar to this pH effect,
we have previously shown that hen egg lysozyme, an
a-helix-rich protein like insulin, loses a-helix content to
random coil (disordered) content on exposure to hydro-
phobic interfaces in less than a few seconds (40). There
was a distinct CD spectrum for insulin samples at pH 11
and those at pH 1.6, regardless of whether the samples
had been previously in the b-sheet rich fibrils. This change
in structure of insulin with pH is confirmed by Pocker and
Biswas (41) and shown in the inset in Fig. 2 B. Insulin has
been shown to have great structural flexibility within a pH
range of 1–7 (39) and this most likely continues until a
pH of 12, where insulin is chemically denatured and does
not return to folded insulin when the pH is lowered. The
gradual increase of molar ellipticity with temperature of
the pH 1.6 insulin (Fig. 2 C) suggests a quaternary structure
change in the insulin from hexamer to dimer to monomer
(42,43). For pH 11 insulin, the protein is most likely already
a dimer, and it retains a classic sigmoidal melt curve with
a melt temperature of 67C (52C). The melt temperature
is the same whether the insulin had been in fibrils (IF) or not
(IN). The structure of the insulin regardless if it had previ-
ously been in fibrils was also predicted to be similar with
DUVRR spectroscopy (Fig. 2 D and Fig. S1 in the Support-
ing Material), which is a sensitive measure of b-sheet
content (44,45).
We attempted to disrupt the disulfide bond interactions
and intermolecular noncovalent bonds within the disaggre-
gated insulin to better understand the source of stability of
the seeding structure. Neither the addition of 5 mM DTT,
5 mM DTTwith 10 min heating at 60C, nor 3 M guanidine
HCl was able to change the seeding behavior of the disag-
gregated insulin fibrils (data not shown). This suggests
that either strong hydrogen bonding or strong hydrophobic
interactions stabilized these aggregates and required >3 M
guanidine HCl to disrupt the seeding action of the stable
reactive species from the disaggregated fibrils.
Although the structure of the insulin appeared to be
similar whether the protein had previously been in fibrils
or not, there was evidence that something had changed in
the insulin that had been in fibrils. Insulin that had previ-
ously been in fibrils (IF and IF
0) had a Thioflavin-T (ThT)
fluorescence, whereas insulin that had been pH-cycled (IN
and IN
0) did not (Fig. 3 A). A non-b-sheet rich structure of
an Ab mutant, as shown by CD, has also been shown to
have a ThT signal (17). Some of the difference in IF and
IF
0 is due to the fluorescence intensity difference in ThT
with pH (Fig. S2), but it is likely that a change in secondary
structure, as shown by the CD in Fig. 2 B, is also responsible
for the intensity difference. The samples with a ThT fluores-
cence intensity >1 decreased the lag time of a new insulin
aggregation run in a dose-dependent manner (Fig. 3 B and
Fig. S3), whereas the samples with a ThT intensity <1 did
not change the lag time of a new insulin run (Fig. S3).This evidence supports the hypothesis that a part of the
fibril, or a reactive species associated with the fibril, did
not dissolve at high pH and remained in solution. We
pursued the separation and analysis of this entity that was
causing both a ThT signal and a decrease in lag time to
produce fibrils.
Large aggregates from disaggregated insulin were discov-
ered using AFM imaging (Fig. 3 C). The aggregates were
48 5 15 nm in diameter and fairly symmetrical in nature.
They were also flat, with an average height of 3 5 1 nm,
compared to fibrils with a height of 3–4 nm. These same
shaped aggregates have also been found in solutions of
native insulin at pH 1.6 that had been at 65C for 90 min
(just before the onset of fibril formation) along with small,
thin protofibrils (Fig. S4). This suggests that the aggregates
found in the disaggregated insulin are also found in the lag
time samples, at least as related to size of the aggregates.
The size of the aggregates appears to be very large, but these
large structures have been seen by others (46,47). It is
possible that the core of these large aggregates contains
the core of the fibril and the aggregate rearranges to form
fibrils. Another possibility is that fibrils use the surface of
the aggregate as a nucleation site and then break away
from the aggregate as they elongate (47,48). Whatever the
mechanism, these aggregates are not found in solutions
before heating to 65C, and therefore must be formed
from the protein during the lag phase of fibril formation.Biophysical Journal 100(11) 2792–2800
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as determined by the MTT cell proliferation assay, using rat
adrenal gland cells (PC-12 adherent), but does not reduce
MTT as much as insulin fibrils (Fig. 3 D). There are many
reports that amyloid fibrils are not toxic to cells
(12,49,50), whereas different cell lines demonstrate toxicity
toward fibrils (5,51,52). The disaggregated insulin is also
toxic to cells, whereas insulin that has not been in fibrils,
or exposed to 65C for extended periods is not toxic. Olig-
omers of amyloid formation are known to be toxic to cells
(53,54), and so this supports the hypothesis that the reactive
species from the disaggregated insulin fibrils are early
formed species involved in fibril formation.Removal of insulin seeding activity
Because the aggregates in the disaggregated insulin were
485 15 nm in size, we removed them with a 0.22 mm filter.
This treatment removed all seeding activity from the disag-
gregated insulin (Fig. 4 A). The aggregates imaged were
smaller than the 220 nm nominal mean pore size of the filter,
but the filter likely acted as a depth filter and the aggregates
adhered to the pore walls of the filter, thus removing them
from solution. The absorbance at 280 nm before and after
filtration did not change measurably; therefore, no percep-
tible amount of dissolved protein was removed from solu-
tion. To better quantify the removal of the aggregates
from solution, the average size of the particles in solution
was measured with SANS (Fig. 4, B and C). The disaggre-FIGURE 4 Removal of seeding behavior by 0.22 mm filtration of disag-
gregated insulin. (A) The kinetics of fibril formation of 2 mg/ml insulin, pH
1.6 and 65C, with 1% fibrils (purple circles), 1% disaggregated insulin
(IF
0) (red squares), 1% of 0.22 mm filtered disaggregated insulin (open
squares) and no seed control (blue diamonds). Empirical line fits were
used to determine the lag time and kinetic elongation rate (1,31). Filtration
with a 0.22 mm filter was able to remove any seeding behavior from the dis-
aggregated insulin (IF
0) (B) SANS spectra for IF (red), IF0 (green), IF0 filtered
with a 0.22 mm filter (open black), and native insulin (blue). (C) Results
from SANS spectra that were analyzed with the Guinier analysis, which
only examines the low Q range.
Biophysical Journal 100(11) 2792–2800gated samples (IF and IF
0) had an average hydrated radius of
gyration (Rg) of 3.935 0.21 and 3.125 0.23 nm, respec-
tively. This is much smaller than the 50–100 nm aggregates
observed with AFM (Fig. 3 C) and this is likely because the
aggregates are very low in concentration, as observed by no
perceptible change in protein concentration when they are
removed with a 0.22 mm filter. When the solution was
filtered (0.22 mm), the value of Rg was reduced to 1.07 5
0.05 nm, which is comparable with the native insulin at
1.27 5 0.01 nm and the theoretical value of 1.4 nm (7).
The Rg and molecular mass were calculated using the Guin-
ier analysis, which is detailed in the SI Text, in Fig. S4 and
summarized in Fig. 4 C.Separation and analysis of insulin seeding
structure
The removal of the entity that seeds the kinetic reaction with
filtration led us to the hypothesis that we could separate this
seeding structure for further analysis. Diafiltration was per-
formed with a 100 kDa molecular mass cut-off membrane
(Fig. 1 C); any protein smaller than 100 kDa would pass
through the membrane and anything larger would be with-
held by the membrane. We hypothesized that any insulin
that was in dimer (11.6 kDa) to hexamer (34.8 kDa) form
would pass through the membrane, whereas larger reactive
species would be retained. This was a method to concentrate
and purify the reactive species for further characterization.
After passing 10 diavolumes of insulin buffer at pH 3
through the membrane (one diavolume is defined as the
volume of liquid in the system at the start), the two fractions
were characterized (Fig. 5). The retentate, or the fraction
that was unable to pass through the 100 kDa membrane,
maintained the seeding ability of the disaggregated insulin
(Fig. 5 A) and was measured as 1% of the total protein
mass by UV/vis spectroscopy, assuming the same absorp-
tion coefficient as native insulin. The measurable protein
content shows that the retentate was not pure insulin reactive
species and most likely contained native insulin. When
samples were subjected to >10 diavolumes, the protein
content continued to drop and CD and DUVRR spectra
could not be obtained. The permeate, or the fraction that
passed through the membrane, did not seed the kinetic reac-
tion and had the same lag time as the control insulin that had
not been in fibrils or pH cycled to pH 11. Through this puri-
fication process of removing native insulin from the sample,
we were able to observe a difference in the CD spectra
(Fig. 5 B) of the retentate and the permeate, but only a small
rise in the Amide I, Amide II, and Ca-H bands in the
DUVRR spectra (55) (Fig. 5 C). The CD spectrum of the
retentate showed a loss of 35% (510%) of the a-helix
and within error there was not a change in b-sheet structure,
with the a-helix loss mainly being compensated by an
increase in unordered structure (34), which was determined
by deconvoluting the CD curve using DichrowWeb (25).
FIGURE 5 Separation of seeding behavior using diafiltration. Insulin was separated by diafiltration as shown in Fig. 1 C. (A) The kinetics of fibril forma-
tion as described in Fig. 4 with 1% retentate (orange circles), 1% permeate (green squares), and no seed control (blue diamonds). (B) CD spectra show the
retentate (orange dots) looses a-helix and permeate (green dashes) have the same structure as the disaggregated insulin (IF
0) (open green triangles) at pH 1.6.
(C) DUVRR shows little change in the b-sheet structure of the retentate (orange dots) as compared to native insulin (blue solid line). Insulin fibrils (purple
dashes) have a large amount of b-sheet structure shown by the increase in the Amide I, Amide II, and Ca-H intensity. (D) Both the retentate (orange dots) and
permeate (green dashes) at pH 1.6 have a continuous melt curve, as seen by native insulin at pH 1.6 in Fig. 2 C. (E) The retentate reduces MTT, whereas the
permeate does not and the retentate has a strong ThT signal, whereas (F) the permeate does not. All samples produce insulin fibrils with similar morphology
(i.e., a height of 3–4 nm and a length of 1–3 mm) after 4 h of incubation (G ii, iv, and vi). The time zero samples (i, iii, and v) showed aggregates in iii the
retentate and v the permeate samples but not (i) the control sample.
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spectroscopy because the small changes evident in Raman
spectra (Fig. 5 B) were indicative of a-helix melting and
formation of unordered structures, which might include
turns (45). The important observation was the lack of any
noticeable contribution from a newly formed b-sheet (45).
Noteworthy here, CD and Raman spectroscopes are compli-
mentary techniques because CD is most sensitive to a-helix
structure and Raman to b-sheet. High specificity and selec-
tivity of DUVRR spectroscopy to b-sheet conformation has
allowed for monitoring directly and characterizing the
nucleation kinetics during lysozyme fibrillation (56). As
a result, we concluded that the seeding structure was more
unordered than native insulin and contained little newly
formed b-sheet, certainly not more than a few percent rela-
tive to the overall secondary structure compassion (the
detection limit of DUVRR spectroscopy).
Permeate continued to display qualities of native insulin,
including no toxicity (i.e., no reduction in MTT signal)
(Fig. 5 E) and a minimal ThT signal (Fig. 5 F), whereas
the retentate displayed all of the qualities of an insulin fibril
oligomer (Fig. 5, E and F and Fig. S6). Even though the time
to formation was different, the fibrils formed from the native
insulin, the seeded retentate, and the seeded permeate all
had similar fibril thickness (3–4 nm) and a length between
1 and 3 mm. The only differences were the amount of
measurable material in the zero time images (Fig. 5 G).
We have shown that regardless of the time it takes for insulin
fibrils to form, the same size and molecular mass oligomer
or nucleus is involved in the process (7), which may explainthat although the oligomers are present at different times
during the reaction, the same species is responsible for fibril
formation and leads to the same fibril structure.DISCUSSION
Some reported methods of dissolving amyloid fibrils have
used guanidine HCl (23), which is a strong protein dena-
turant, and destabilizing osmolyte, DMSO (24), and ionic
liquids (25). Lipids have also been shown to break down
Ab fibrils into toxic protofibrils (57), as well as high pH
(26). Only in the case of the ionic liquid was protein activity
recovered. However, for the study of lysozyme amyloid
fibrils dissolution with ionic liquids, the focus of the study
was on the large amount of lysozyme that remained active,
but there may have been a small amount of lysozyme that
did not refold into normally active lysozyme. All of the
solvents, with exception to DMSO (58), greatly disrupt ionic
or charge interactions of proteins (59), including high pH.
High pH was able to disrupt most of the fibril interactions
and release close to native folded insulin, demonstrating
that the fibril interactions are strongly electrostatic (60).
The model by Eisenberg and co-workers show two different
interactions dominate the insulin fibril core, a dry steric
zipper that is dominated by hydrophobic interactions and
a water containing layer that is likely hydrogen bonding
(29). By disruption of the hydrogen-bonding layer, the fibril
appears to dissociate and release insulin. Yet from our study,
there appears to be a reactive species that is not disturbed
under high pH conditions.Biophysical Journal 100(11) 2792–2800
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of insulin: one that seeded the reaction and decreased the lag
time and one that did not affect the reaction. The majority of
the insulin (>99%) is in the later population and had no
noticeable effect on the seeding reaction. The release of
active peptides from amyloid fibrils has been demonstrated
for many different hormones (52), but the activity of the
nonnatively folded peptides was not examined, if they ex-
isted. Here, we focused on the small population that does
seed the insulin fibril formation reaction, not the released
insulin. It appears that the seeding phenomenon is caused
by a large structure of insulin that is ~485 15 nm in diam-
eter (Fig. 3 C). We hypothesize that this large structure is
a reactive species and is stable at pH 11. The origin of
this species is likely from one of three possibilities, as
shown schematically in Fig. 6, either the fibrils rearrange
during dissolution and form the reactive species, the reactive
species is an integral part of the fibrils, or the reactiveFIGURE 6 Cartoon of suggested insulin fibril formation and disaggre-
gation. Native insulin at pH 1.6 and 65C undergoes a molecular rear-
rangement to reactive species during the fibril formation lag time,
shown in the upper right. The process continues at 65C until some event
causes the fibrils to elongate. Finally, an asymptotic phase is reached when
no free insulin is left in solution to elongate the fibrils. When the fibrils are
placed at pH 11 and 20C, there appears to create a solution that is similar,
if not the same, as the reactive species formation phase found during the
lag time. We reach this conclusion by the same sized aggregates that are
imaged in prefibrillar and disaggregated samples (Fig. S4 B and Fig. 3 C)
and that the disaggregated solution is toxic (Fig. 3 D). We hypothesize that
either i), the fibrils are uniform or the reactive species are refolded during
the disaggregation process, ii), the fibrils contain the reactive species and
the reactive species are released during high pH disaggregation, or iii), the
reactive species are associated with the fibrils and are stable and do not
dissolve at high pH.
Biophysical Journal 100(11) 2792–2800species is present in solution and associated with the fibrils.
This reactive species is not b-sheet rich, but contains rather
disordered protein structure. Recently, stable oligomers of
Ab have been formed with either the addition of surfactants
(61) or by the stabilization of a b-hairpin using engineered
disulfide bonds (14). Both of these structures contain
some form of b-sheet structure, yet they were formed in
a different manner than we have formed here. Dobson and
co-workers have shown that the b-hairpin constrained
formation does not form fibrils and state that it is possible
for high molecular mass aggregates, which are 19–25 nm
in diameter and bind to the A11 antibody, to form fibrils
(14). We may have produced what Dobson and co-workers
term high molecular weight aggregates in our experiments
by high pH dissolution of insulin fibrils. Both species
have minimal b-sheet content and are considered unstruc-
tured. Similar high molecular weight aggregates have also
been found in vivo (15), leading us to suggest that these
aggregates may be oligomers that are on the pathway to
fibril formation and incorporated into or adsorbed onto the
fibrils. In the past, we have used cooling experiments to
demonstrate that insulin oligomers, when removed from
the fibrillation reaction and cooled to room temperature
for 1–28 days, continue to form nuclei that are unable to
from fibrils at the colder temperature, but easily do so
when seeded at the original high temperature (31). We
have also shown through seeding experiments that fibrils
prefer to grow asymmetrically and usually at a constant
rate (32). This suggests that the reactive species isolated
here from fibril disaggregation are formed during the lag
time, but have not been previously studied because a b-sheet
rich structure are often being sought for study, not the struc-
ture reported here. As stated by others, many different
aggregates are formed from amyloid proteins and not all
form fibrils (14,62,63). This reverse-engineering approach
of dissolving fibrils created structures that either preexist
in or on the fibril or are created during the process of fibril
dissolution and seed the reaction to form additional fibrils.SUPPORTING MATERIAL
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